Day: May 16, 2024

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

Dallas, Texas, May 16, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies today announced that it has recently reported noteworthy growth in both revenue and customer acquisition in the first quarter ended March 31, 2024 as compared to the quarter ended March 31, 2023. Specifically, the company reported an impressive 108% increase in sales, growing from $214,000 USD compared to approximately $100,000 USD in the first quarter of 2023. This revenue growth demonstrates a positive trajectory for the company’s financial performance in Q1 2024. In addition to achieving significant revenue growth, MangoRx...

Continue reading

<div>Park Hotels & Resorts Announces Final Results of Tender Offer</div>

Park Hotels & Resorts Announces Final Results of Tender Offer

TYSONS, Va., May 16, 2024 (GLOBE NEWSWIRE) — Park Hotels & Resorts Inc. (“Park”) (NYSE: PK) announced today the expiration of and the final results for the previously announced offer to purchase for cash (the “Tender Offer”) commenced by Park’s subsidiaries, Park Intermediate Holdings LLC, a Delaware limited liability (the “Company”), PK Domestic Property LLC, a Delaware limited liability company, and PK Finance Co-Issuer Inc., a Delaware corporation (collectively, the “Issuers”), for any and all of their outstanding 7.500% Senior Notes due 2025 (the “Notes”). The Tender Offer expired at 5:00 p.m., New York City time, on May 13, 2024 (the “Expiration Time”). On May 16, 2024, the Issuers purchased $311,473,000 in principal amount of the Notes that were validly tendered and not validly withdrawn or with respect to which a properly...

Continue reading

Gaming and Leisure Properties Announces the Acquisition of Three Casino Resorts in South Dakota and Nevada for $105 Million and Establishes New Tenant Relationship With Strategic Gaming Management

Gaming and Leisure Properties Announces the Acquisition of Three Casino Resorts in South Dakota and Nevada for $105 Million and Establishes New Tenant Relationship With Strategic Gaming Management

Transaction is Expected to be Immediately Accretive WYOMISSING, Pa., May 16, 2024 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI”) today acquired the real estate assets of the Silverado Franklin Hotel & Gaming Complex (“Silverado”), the Deadwood Mountain Grand (“DMG”) casino, and Baldini’s Casino (“Baldini’s”), for $105.0 million in aggregate. Simultaneous with the acquisition, GLPI and affiliates of Strategic Gaming Management, LLC (“Strategic”) will enter into two cross-defaulted triple-net lease agreements, each for an initial 25-year term with two ten-year renewal periods. GLPI also provided $5 million in capital improvement proceeds at the closing of the transactions for a total investment of $110 million. The initial aggregate annual cash rent for the new leases is $9.2 million, inclusive...

Continue reading

ATS 2024: New ResMed-Supported Research Shows  Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) — When:          May 17–22, 2024Where:         San Diego Convention Center (SDCC) | 111 Harbor Dr. San Diego, CA 92101                       Marriott Marquis San Diego Marina | 333 West Harbor Dr. San Diego, CA 92101 Research:     26 ResMed-supported abstracts will be presented at ATS. Full list below. Highlights: Treatment of Sleep-Disordered Breathing with Adaptive Servo-Ventilation (READ-ASV) in Opioid Users – a European Registry Sunday May 19, 2024, 9:15 a.m. – 11:15 a.m., SDCC 32A-B Presented by Jean-Louis Pepin, MD, Grenoble Alpes University, France An Estimate of the Prevalence of Obstructive Sleep Apnea in the United States into 2050 Monday, May 20, 9:15 a.m. – 4:15 p.m., SDCC Area C Hall A-B2 Presented by Elroy Boers, PhD, ResMed Science Center All-Cause Mortality...

Continue reading

<div>Park Hotels & Resorts Inc Announces Closing of $550 Million of 7.000% Senior Notes Due 2030</div>

Park Hotels & Resorts Inc Announces Closing of $550 Million of 7.000% Senior Notes Due 2030

TYSONS, Va., May 16, 2024 (GLOBE NEWSWIRE) — Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE: PK) announced today that certain of its subsidiaries, Park Intermediate Holdings LLC (the “Operating Company”), PK Domestic Property LLC (“PK Domestic LLC”) and PK Finance Co-Issuer Inc. (together with the Operating Company and PK Domestic LLC, the “Issuers”), completed the previously announced offering of $550 million aggregate principal amount of 7.000% senior notes due 2030 (the “Notes”). The Notes will pay interest semi-annually in arrears, at a rate of 7.000% per year, and will mature on February 1, 2030. The Notes are guaranteed by Park, PK Domestic REIT Inc. and certain subsidiaries of the Operating Company that guarantee the Company’s credit agreement and existing senior notes due 2025, 2028, and 2029. The Issuers...

Continue reading

American Oncology Network Appoints New Board Member

American Oncology Network Appoints New Board Member

William “Bill” J. Valle joins AON’s Board of Directors. American Oncology Network Appoints New Board Member From left to right: William “Bill” J. Valle, AON’s newest board member; Stephen “Fred” Divers, MD, AON’s chief medical officer; and Todd Schonherz, AON’s chief executive officer. FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) — American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks of community oncology practices, is pleased to announce the appointment of William “Bill” J. Valle to its Board of Directors, effective April 19, 2024. “On behalf of the Board, I am honored to be officially welcoming Bill,” said Stephen “Fred” Divers, MD, AON’s chief medical officer and vice chairman of the Board. “Bill has extensive experience and knowledge...

Continue reading

Pennant Acquires South Texas Hospice Provider

Pennant Acquires South Texas Hospice Provider

EAGLE, Idaho, May 16, 2024 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has acquired Nurses on Wheels, Inc. (“Nurses on Wheels”), which provides hospice services in Corpus Christi, Texas and the surrounding communities. “We are excited to expand the reach of our hospice operations in south Texas,” said Brent Guerisoli, Chief Executive Officer of Pennant. “Our strategy of empowering local leaders to meet the needs of local communities has resonated deeply across our platform and we look forward to bringing our innovative operating model and high-quality resources to enhance the services offered in south Texas.” Guerisoli added. “Nurses on Wheels has a deep connection to Corpus Christ...

Continue reading

NL INDUSTRIES, INC. ANNOUNCES QUARTERLY DIVIDEND AND RESULTS OF ANNUAL SHAREHOLDER MEETING

NL INDUSTRIES, INC. ANNOUNCES QUARTERLY DIVIDEND AND RESULTS OF ANNUAL SHAREHOLDER MEETING

Dallas, Texas, May 16, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE:  NL) announced that its board of directors has declared a quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 25, 2024 to shareholders of record at the close of business on June 10, 2024. NL Industries also announced that at its 2024 annual shareholder meeting held today its shareholders had: elected each of Loretta J. Feehan, John E. Harper, Kevin B. Kramer, Meredith W. Mendes, Cecil H. Moore, Jr., Courtney J. Riley and Michael S. Simmons as a director for a one-year term; and adopted a resolution that approved, on a nonbinding advisory basis, the compensation of its named executive officers as disclosed in the proxy statement for the 2024 annual shareholder meeting. NL Industries, Inc. is engaged in the component products...

Continue reading

Applied Materials Announces Second Quarter 2024 Results

Applied Materials Announces Second Quarter 2024 Results

Revenue $6.65 billion, flat year over year GAAP operating margin 28.8 percent and non-GAAP operating margin 29.0 percent, flat and down 0.1 point year over year, respectively GAAP EPS $2.06 and non-GAAP EPS $2.09, up 11 percent and 5 percent year over year, respectively Generated $1.39 billion in cash from operations SANTA CLARA, Calif., May 16, 2024 (GLOBE NEWSWIRE) —  Applied Materials, Inc. (NASDAQ: AMAT) today reported results for its second quarter ended Apr. 28, 2024. Second Quarter Results Applied generated revenue of $6.65 billion. On a GAAP basis, the company reported gross margin of 47.4 percent, operating income of $1.91 billion or 28.8 percent of net revenue, and earnings per share (EPS) of $2.06. On a non-GAAP basis, the company reported gross margin of 47.5 percent, operating income of $1.93 billion or 29.0 percent...

Continue reading

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

Key Data Readouts on Track for All Programs in 2024 Randomized Phase 2 Study of 182 Second-Line Colorectal Cancer Patients Fully Enrolled NUC-7738 plus Pembrolizumab Demonstrated Encouraging Anti-Cancer Activity in Several Patients who were Resistant to PD-1 Inhibitors Anticipated Cash Runway into Q1 2025 EDINBURGH, United Kingdom, May 16, 2024 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the first quarter ended March 31, 2024 and provided an update on its broad clinical development program with its transformative ProTide therapeutics. As of March 31, 2024, NuCana had cash and cash equivalents of £12.9 million compared to £17.2 million at December 31, 2023. NuCana continues to advance its numerous clinical programs and reported a net loss of £6.8 million for the quarter ended March 31, 2024, as compared...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.